Costs of treatment of adult patients with cystic fibrosis in Poland and internationally.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Public Health

• Publication date

  2017-07-01

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1016/j.puhe.2017.03.003PMID 28404533
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Costs and health-related quality of life of patients with cystic fibrosis and their carers in France.

  2015cited by this paper
• Economic Burden And Health-Related Quality Of Life Of Patients With Cystic Fibrosis In Bulgaria

  2015cited by this paper
• Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom

  2015cited by this paper
• Cost of care for cystic fibrosis: an investigation of cost determinants using national registry data

  2015cited by this paper
• Understanding the costs of care for cystic fibrosis: an analysis by age and health state.

  2013cited by this paper
• Economic Burden of Non-Cystic Fibrosis Bronchiectasis in the First Year after Diagnosis from A US Health Plan Perspective

  2013cited by this paper
• Economic and social burden of cystic fibrosis in Poland. Estimates based on patients - reported data

  2013cited by this paper
• Resource use, costs, and utility estimates for patients with cystic fibrosis with mild impairment in lung function: analysis of data collected alongside a 48-week multicenter clinical trial.

  2012cited by this paper
• How to Calculate Indirect Costs in Economic Evaluations

  2012cited by this paper
• Cost of Illness of Cystic Fibrosis in Germany

  2012cited by this paper
• Cystic fibrosis

  2012cited by this paper
• Cystic Fibrosis

  2009cited by this paper
• Healthcare expenditures for privately insured people with cystic fibrosis

  2009cited by this paper
• Evolution of costs of care for cystic fibrosis patients after clinical guidelines implementation in a French network.

  2008cited by this paper
• The prevalence of cystic fibrosis in the European Union.

  2008cited by this paper
• Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France

  2006cited by this paper
• Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies.

  2003cited by this paper
• Cost of care and clinical condition in paediatric cystic fibrosis patients.

  2003cited by this paper
• Prenatal screening for cystic fibrosis: an economic analysis.

  2002cited by this paper
• The Cost of Medical Care for Patients With Cystic Fibrosis in a Health Maintenance Organization

  1999cited by this paper
• Cost of Care for Individuals with Cystic Fibrosis: A Regression Approach to Determining the Impact of Recombinant Human DNase

  1999cited by this paper
• Cost of care of patients with cystic fibrosis in The Netherlands in 1990-1.

  1996cited by this paper
• Cost-of-illness studies: fact or fiction?

  1994cited by this paper
• Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes

  1988cited by this paper

• Validation and psychometric properties of the Consumer Financial Protection Bureau Financial Well-Being Scale (CFPB-FWBS) for Polish family caregivers of individuals with rare diseases

  2025cites this paper
• A Comprehensive View of the Methods Used to Measure the Societal Impact of Healthcare Interventions: A Systematic Review.

  2025cites this paper
• Measuring economic burden in families of individuals with Angelman Syndrome in Poland: a caregivers’ survey

  2025cites this paper
• Direct healthcare costs in the first 2 years of life: A comparison of screened and clinically diagnosed children with cystic fibrosis - The Irish comparative outcomes study of CF (ICOS).

  2024cites this paper
• Measuring the burden of cystic fibrosis: A scoping review.

  2023cites this paper
• Economic burden of cystic fibrosis care in British Columbia

  2023cites this paper
• Factors associated with frequent high-cost individuals with cystic fibrosis and their healthcare utilization and cost patterns

  2023cites this paper
• Fat-Soluble Vitamins in Standard vs. Liposomal Form Enriched with Vitamin K2 in Cystic Fibrosis: A Randomized Multi-Center Trial

  2022cites this paper
• Reflections on the Importance of Cost of Illness Analysis in Rare Diseases: A Proposal

  2021cites this paper
• Temporal trends in healthcare resource use and associated costs of patients with cystic fibrosis.

  2021cites this paper
• Cost-of-illness studies in rare diseases: a scoping review

  2021cites this paper
• Hospital costs of Canadian cystic fibrosis patients

  2021cites this paper
• Муковисцидоз как социально-экономическая проблема

  2021cites this paper
• Hospitalization Costs of Canadian Cystic Fibrosis Patients

  2020cites this paper
• Unveiling epidemiology and treatment strategies for efficient management of lung infection in cystic fibrosis

  2020cites this paper
• Cystic fibrosis outpatient treatment and medical costs: a retrospective analysis

  2020cites this paper
• The Economic Burden of Cystic Fibrosis in Germany from a Payer Perspective

  2019cites this paper